Abstract
Synovitis is an important component of the osteoarthritis (OA) disease process, particularly regarding the “inflammatory phenotype” of OA. Imaging plays an important role in the assessment of synovitis in OA with MRI and ultrasound being the most deployed imaging modalities. Contrast-enhanced (CE) MRI, particularly dynamic CEMRI (DCEMRI) is the ideal method for synovitis assessment, but for several reasons CEMRI is not commonly performed for OA imaging in general. Effusion-synovitis and Hoffa-synovitis are commonly used as surrogate markers of synovitis on non-contrast-enhanced (NCE) MRI and have been used in many epidemiological observational studies of knee OA. Several semiquantitative MRI scoring systems are available for the evaluation of synovitis in knee OA. Synovitis can be a target tissue for disease-modifying OA drug (DMOAD) clinical trials. Both MRI and ultrasound may be used to determine the eligibility and assess the therapeutic efficacy of DMOAD approaches. Ultrasound is mostly used for evaluation of synovitis in hand OA, while MRI is typically used for larger joints, namely knees and hips. The role of other modalities such as CT (including dual-energy CT) and nuclear medicine imaging (such as positron-emission tomography (PET) and its hybrid imaging) is limited in the context of synovitis assessment in OA. Despite research efforts to develop NCEMRI-based synovitis evaluation methods, these typically underestimate the severity of synovitis compared to CEMRI, and thus more research is needed before we can rely only on NCEMRI.
Similar content being viewed by others
References
Roemer FW, Collins J, Kwoh CK, et al. MRI-based screening for structural definition of eligibility in clinical DMOAD trials: Rapid OsteoArthritis MRI Eligibility Score (ROAMES). Osteoarthritis Cartilage. 2020;28:71–81.
Rollin R, Marco F, Jover JA, Garcia-Asenjo JA, Rodriguez L, Lopez-Duran L, et al. Early lymphocyte activation in the synovial microenvironment in patients with osteoarthritis: comparison with rheumatoid arthritis patients and healthy controls. Rheumatol Int. 2008;28:757–64.
Dainese P, Wyngaert KV, De Mits S, Wittoek R, Van Ginckel A, Calders P. Association between knee inflammation and knee pain in patients with knee osteoarthritis: a systematic review. Osteoarthritis Cartilage. 2022;30(4):516–34.
Brandt KD, Dieppe P, Radin E. Etiopathogenesis of osteoarthritis. Med Clin N Am. 2009;93:1–24.
Myers SL, Brandt KD, Ehlich JW, Braunstein EM, Shelbourne KD, Heck DA, et al. Synovial inflammation in patients with early osteoarthritis of the knee. J Rheumatol. 1990;17:1662–9.
Loeuille D, Rat AC, Goebel JC, Champigneulle J, Blum A, Netter P, et al. Magnetic resonance imaging in osteoarthritis: which method best reflects synovial membrane inflammation? Correlations with clinical, macroscopic and microscopic features. Osteoarthritis Cartilage. 2009;17:1186–92.
Peterfy CG, Guermazi A, Zaim S, Tirman PF, Miaux Y, White D, et al. whole-organ magnetic resonance imaging score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage. 2004;12(3):177–90.
Roemer FW, Frobell R, Lohmander LS, Niu J, Guermazi A. Anterior cruciate ligament osteoarthritis score (ACLOAS): longitudinal MRI-based whole joint assessment of anterior cruciate ligament injury. Osteoarthritis Cartilage. 2014;22(5):668–82.
Roemer FW, Guermazi A, Trattnig S, Apprich S, Marlovits S, Niu J, et al. Whole joint MRI assessment of surgical cartilage repair of the knee: Cartilage Repair OsteoArthritis Knee Score (CROAKS). Osteoarthritis Cartilage. 2014;22(6):779–99.
Hunter DJ, Guermazi A, Lo GH, et al. Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score). Osteoarthritis Cartilage. 2011;19:990–1002.
Guermazi A, Roemer FW, Hayashi D, et al. Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study. Ann Rheum Dis. 2011;70:805–11.
Wang X, Chen T, Liang W, Fan T, Zhu Z, Cao P, et al. Synovitis mediates the association between bone marrow lesions and knee pain in osteoarthritis: data from the Foundation for the National Institute of Health (FNIH) Osteoarthritis Biomarkers Consortium. Osteoarthritis Cartilage. 2022;30(9):1270–7.
Bañuls-Mirete M, Lombardi AF, Posis AIB, Shadyab AH, Chang EY, Lane NE, et al. Effusion-synovitis worsening mediates the association between body mass index and Kellgren-Lawrence progression in obese individuals: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2022;30(9):1278–86.
Sasaki E, Yamamoto H, Asari T, Matsuta R, Ota S, Kimura Y, et al. Metabolomics with severity of radiographic knee osteoarthritis and early phase synovitis in middle-aged women from the Iwaki Health Promotion Project: a cross-sectional study. Arthritis Res Ther. 2022;24(1):145.
Ramezanpour S, Kanthawang T, Lynch J, McCulloch CE, Nevitt MC, Link TM, et al. Impact of sustained synovitis on knee joint structural degeneration: 4-year MRI data from the Osteoarthritis Initiative. J Magn Reson Imaging. 2023;57(1):153–64.
Macri EM, Neogi T, Jarraya M, Guermazi A, Roemer F, Lewis CE, et al. Magnetic resonance imaging-defined osteoarthritis features and anterior knee pain in individuals with, or at risk for, knee osteoarthritis: a multicenter study on osteoarthritis. Arthritis Care Res (Hoboken). 2022;74(9):1533–40.
Roemer FW, Guermazi A, Hannon MJ, Fujii T, Omoumi P, Hunter DJ, et al. Presence of magnetic resonance imaging-defined inflammation particularly in overweight and obese women increases risk of radiographic knee osteoarthritis: the POMA study. Arthritis Care Res (Hoboken). 2022;74(8):1391–8.
Hart HF, Culvenor AG, Patterson BE, Doshi A, Vora A, Guermazi A, et al. Infrapatellar fat pad volume and Hoffa-synovitis after ACL reconstruction: association with early osteoarthritis features and pain over 5 years. J Orthop Res. 2022;40(1):260–7.
Hunter DJ, Deveza LA, Collins JE, Losina E, Katz JN, Nevitt MC, et al. Multivariable modeling of biomarker data from the PhaseI Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium. Arthritis Care Res (Hoboken). 2022;74(7):1142–53.
Driban JB, Price LL, LaValley MP, Lo GH, Zhang M, Harkey MS, et al. Novel framework for measuring whole knee osteoarthritis progression using magnetic resonance imaging. Arthritis Care Res (Hoboken). 2022;74(5):799–808.
Damman W, Liu R, Reijnierse M, Rosendaal FR, Bloem JL, Kloppenburg M. Effusion attenuates the effect of synovitis on radiographic progression in patients with hand osteoarthritis: a longitudinal magnetic resonance imaging study. Clin Rheumatol. 2021;40(1):315–9.
Ahedi H, Aitken D, Blizzard L, Cicuttini F, Jones G. Quantification of hip effusion-synovitis and its cross-sectional and longitudinal associations with hip pain, MRI findings and early radiographic hip OA. BMC Musculoskelet Disord. 2020;21(1):533.
Kanthawang T, Bodden J, Joseph GB, Lane NE, Nevitt M, McCulloch CE, et al. Obese and overweight individuals have greater knee synovial inflammation and associated structural and cartilage compositional degeneration: data from the osteoarthritis initiative. Skeletal Radiol. 2021;50(1):217–29.
Zhu Z, Yu Q, Leng X, Han W, Li Z, Huang C, et al. Can low-dose methotrexate reduce effusion-synovitis and symptoms in patients with mid- to late-stage knee osteoarthritis? Study protocol for a randomized, double-blind, and placebo-controlled trial. Trials. 2022;21(1):795.
Wang Z, Jones G, Winzenberg T, Cai G, Laslett LL, Aitken D, et al. Effectiveness of curcuma longa extract for the treatment of symptoms and effusion-synovitis of knee osteoarthritis: a randomized trial. Ann Intern Med. 2020;173(11):861–9.
Roemer FW, Kraines J, Aydemir A, Wax S, Hochberg MC, Crema MD, et al. Evaluating the structural effects of intra-articular sprifermin on cartilage and non-cartilaginous tissue alterations, based on sqMRI assessment over 2 years. Osteoarthritis Cartilage. 2020;28(9):1229–2123.
Cai G, Jones G, Cicuttini FM, Wluka AE, Wang Y, Hill C, et al. Study protocol for a randomized controlled trial of diacerein versus placebo to treat knee osteoarthritis with effusion-synovitis (DICKENS). Trials. 2022;23(1):768.
Hunter DJ, Lo GH, Gale D, Grainger AJ, Guermazi A, Conaghan PG. The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score). Ann Rheum Dis. 2008;67(2):206–11.
Haugen IK, Østergaard M, Eshed I, McQueen FM, Bird P, Gandjbakhch F, et al. Iterative development and reliability of the OMERACT hand osteoarthritis MRI scoring system. J Rheumatol. 2014;41(2):386–91.
Kroon FPB, Conaghan PG, Foltz V, Gandjbakhch F, Peterfy C, Eshed I, et al. Development and reliability of the OMERACT thumb base osteoarthritis magnetic resonance imaging scoring system. J Rheumatol. 2017;44(11):1694–8.
Roemer FW, Hunter DJ, Winterstein A, Li L, Kim YJ, Cibere J, et al. Hip osteoarthritis MRI scoring system (HOAMS): reliability and associations with radiographic and clinical findings. Osteoarthritis Cartilage. 2011;19(8):946–62.
Lee S, Nardo L, Kumar D, Wyatt CR, Souza RB, Lynch J, et al. Scoring hip osteoarthritis with MRI (SHOMRI): a whole joint osteoarthritis evaluation system. J Magn Reason Imaging. 2015;41(6):1549–57.
Fernandez-Madrid F, Karvonen RL, Teitge RA, Miller PR, An T, Negendank WG. Synovial thickening detected by MR imaging in osteoarthritis of the knee confirmed by biopsy as synovitis. Magn Reson Imaging. 1995;13:177e83.
de Vries BA, van der Heijden RA, Poot DHJ, van Middelkoop M, Meuffels DE, Krestin GP, et al. Quantitative DCE-MRI demonstrates increased blood perfusion in Hoffa’s fat pad signal abnormalities in knee osteoarthritis, but not in patellofemoral pain. Eur Radiol. 2020;30(6):3401–8.
Raman S, Gold GE, Rosen MS, Sveinsson B. Automatic estimation of knee effusion from limited MRI data. Sci Rep. 2022;12(1):3155.
Perry TA, Yang X, van Santen J, Arden NK, Kluzek S. Quantitative and semi-quantitative assessment of synovitis on MRI and the relationship with symptoms in symptomatic knee osteoarthritis. Rheumatology. 2020;28(6):766–73.
MacKay JW, Nezhad FS, Rifai T, Kaggie JD, Naish JH, Roberts C, et al. Dynamic contrast-enhanced MRI of synovitis in knee osteoarthritis: repeatability, discrimination and sensitivity to change in a prospective experimental study. Eur Radiol. 2021;31(8):5746–58.
Daugaard CL, Henriksen M, Riis RGC, Bandak E, Nybing JD, Hangaard S, et al. The impact of a significant weight loss on inflammation assessed on DCE-MRI and static MRI in knee osteoarthritis: a prospective cohort study. Osteoarthr Cartil. 2020;28(6):766–73.
Thoenen J, Stevens KJ, Turmezei TD, Chaudhari A, Watkins LE, McWalter EJ, et al. Non-contrast MRI of synovitis in the knee using quantitative DESS. Eur Radiol. 2021;31(12):9369–79.
de Vries BA, Breda SJ, Sveinsson B, McWalter EJ, Meuffels DE, Krestin GP, et al. Detection of knee synovitis using non-contrast-enhanced qDESS compared with contrast-enhanced MRI. Arthritis Res Ther. 2021;23(1):55.
Sandford HJC, MacKay JW, Watkins LE, Gold GE, Kogan F, Mazzoli V. Gadolinium-free assessment of synovitis using diffusion tensor imaging. NMR Biomed. 2022;35(1):e4614.
Kuettel D, Terslev L, Weber U, Ostergaard M, Primdahl J, Petersen R, et al. Flares in rheumatoid arthritis: do patient-reported swollen and tender joints match clinical and ultrasonography findings? Rheumatology (Oxford). 2020;59:129–36.
de Vries BA, Breda SJ, Meuffels DE, Hanff DF, Hunink MGM, Krestin GP, et al. Diagnostic accuracy of grayscale, power Doppler, and contrast-enhanced ultrasound compared to contrast-enhanced MRI in the visualization of synovitis in knee osteoarthritis. Eur J Radiol. 2020;133:109392.
van de Stadt LA, Kroon FPB, Rosendaal FR, van der Heijde D, Reijnierse M, Riyazi N, et al. Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis. Rheumatology (Oxford). 2022;61(S1):S165–72.
Paskins Z, Bromley K, Lewis M, Hughes G, Hughes E, Hennings S, et al. Clinical effectiveness of one ultrasound guided intra-articular corticosteroid and local anaesthetic injection in addition to advice and education for hip osteoarthritis (HIT trial): single blind, parallel group, three arm, randomized controlled trial. BMJ. 2022;377:e068446.
Ulas T, Ziegeler K, Richter ST, Ohrndorf S, Biesen R, Proft F, et al. Contrast-enhanced CT techniques and MRI perform equally well in arthritis imaging of the hand: a prospective diagnostic accuracy study. Eur Radiol. 2022;32(9):6376–83.
Ulas T, Ziegler K, Richter ST, Ohrndorf S, Proft F, Poddubnyy D, et al. Virtual monochromatic images from dual-energy computed tomography do not improve the detection of synovitis in hand arthritis. Diagnostic (Basel). 2022;12(8):1891.
MacKay JW, Watkins L, Gold G, Kogan F. [18F]NaF PET-MRI provides direct in-vivo evidence of the association between bone metabolic activity and adjacent synovitis in knee osteoarthritis: a cross-sectional study. Osteoarthritis Cartilage. 2021;29(8):1155–62.
Abdelhafez Y, Hagge R, Badawi RD, Raychaudhuri SP, Chaudhari AJ. Early and delayed 99mTc-MDP SPECT/CT findings in rheumatoid arthritis and osteoarthritis. Clin Nucl Med. 2017;42:e480–1.
Abdelhafez YG, Godinez F, Sood K, et al. Feasibility of dual-phase 99mTc-MDP SPECT/CT imaging in rheumatoid arthritis evaluation. Quant Imaging Med Surg. 2021;11:2333–43.
Helo Y, Searle GE, Borghese F, Abraham S, Saleem A. Specificity of translocator protein-targeted positron emission tomography in inflammatory joint disease. EJNMMI Res. 2020;10:147.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
DH received publication royalties from Wolters Kluwer. FWR is a consultant to Calibr and Grünenthal. He is a shareholder to of Boston Imaging Core Lab., LLC. MJ has nothing to disclose. AG received consultancy fees from Pfizer, Novartis, MerckSerono, TissueGene, AstraZeneca, and Regeneron. He is a shareholder of Boston Imaging Core Lab., LLC.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key points
• Synovitis is an important component of the osteoarthritis (OA) disease process, particularly in the “inflammatory phenotype” of OA.
• Imaging plays an important role in the assessment of synovitis in OA.
• Contrast-enhanced MRI (CEMRI) and particularly dynamic CEMRI are the ideal methods for synovitis assessment in a research and clinical trial setting.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hayashi, D., Roemer, F.W., Jarraya, M. et al. Update on recent developments in imaging of inflammation in osteoarthritis: a narrative review. Skeletal Radiol 52, 2057–2067 (2023). https://doi.org/10.1007/s00256-022-04267-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-022-04267-3